IL-17 Signaling Triggers Degradation of the Constitutive NF-κB Inhibitor ABIN-1
Open accessThe DOI matches its Crossref record; 43 of the 44 references it cites were found in a registry or an index.
Abstract
Abstract IL-17 activates NF-κB and induces expression of proinflammatory genes. IL-17 drives disease in autoimmune conditions, and anti–IL-17 Abs have shown impressive success in the clinic. Although produced by lymphocytes, IL-17 predominantly signals in fibroblasts and epithelial cells. IL-17–driven inflammation is kept in check by negative feedback signaling molecules, including the ubiquitin editing enzyme A20, whose gene TNFAIP3 is linked to autoimmune disease susceptibility. The A20 binding inhibitor of NF-κB activation 1 (ABIN-1) is an A20-binding protein encoded by the TNIP1 gene, which is also linked to autoimmune disease susceptibility including psoriasis. Accordingly, we hypothesized that ABIN-1 might play a role in negatively regulating IL-17 signaling activity. Indeed, ABIN-1 enhanced both tonic and IL-17–dependent NF-κB signaling in IL-17–responsive fibroblast cells. Interestingly, the inhibitory activities of ABIN-1 on IL-17 signaling were independent of A20. ABIN-1 is a known NF-κB target gene, and we found that IL-17–induced activation of NF-κB led to enhanced ABIN-1 mRNA expression and promoter activity. Surprisingly, however, the ABIN-1 protein was inducibly degraded following IL-17 signaling in a proteasome-dependent manner. Thus, ABIN-1, acting independently of A20, restricts both baseline and IL-17–induced inflammatory gene expression. We conclude that IL-17–induced signals lead to degradation of ABIN-1, thereby releasing a constitutive cellular brake on NF-κB activation.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“IL-17-NF-κB signaling induces several negative feedback circuits that restrain NF-κB activation, including deubiquitinating enzymes or related factors, including A20 (TNFAIP3), Abin-1 (TNIP1) and USP25”
From The IL-17 Family of Cytokines in Health and Disease (2019) · cites this paper as Cruz et al., 2017
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Secukinumab in plaque psoriasis—results of two phase 3 trials
Langley, R. G., Elewski, B. E., Lebwohl, M., Reich, K., Griffiths, C. E. M., Papp, K., Puig, L., Nakagawa, H., Spelman, L., Sigurgeirsson, B., et al. (2014) · New England Journal of Medicine · doi:10.1056/nejmoa1314258 · Cited by 1,997
The non-canonical NF-κB pathway in immunity and inflammation
Sun, S.-C. (2017) · Nature Reviews Immunology · doi:10.1038/nri.2017.52 · Cited by 1,891 · cited 1×
“Moreover, the gene encoding IkBa is induced in an NF-kB–dependent manner, establishing a negative feedback loop (23).”
BackgroundThe IL-23-IL-17 immune axis: from mechanisms to therapeutic testing
Gaffen, S. L., Jain, R., Garg, A. V., & Cua, D. J. (2014) · Nature reviews. Immunology · doi:10.1038/nri3707 · Cited by 1,585 · cited 2×
“IL-17 blocking therapies have shown considerable efficacy in treating psoriatic patients, and are being evaluated for various other conditions (2).”
BackgroundSelf-citationHerpesvirus Saimiri encodes a new cytokine, IL-17, which binds to a novel cytokine receptor
Yao, Z., Fanslow, W. C., Seldin, M. F., Rousseau, A.-M., Painter, S. L., Comeau, M. R., Cohen, J. I., & Spriggs, M. K. (1995) · Immunity · doi:10.1016/1074-7613(95)90070-5 · Cited by 994 · cited 1×
“In the case of IL-17R signaling, the proximal adaptor Act1 is degraded following phosphorylation to temper all downstream signaling events (40), and IkBa is degraded followingphosphorylation tounmask theNF-kBnuclear import signal (41).”
BackgroundAnti–Interleukin-17 Monoclonal Antibody Ixekizumab in Chronic Plaque Psoriasis
Leonardi, C., Matheson, R., Zachariae, C., Cameron, G., Li, L., Edson-Heredia, E., Braun, D., & Banerjee, S. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1109997 · Cited by 936
Interleukin-17 and its target genes: mechanisms of interleukin-17 function in disease
Onishi, R. M., & Gaffen, S. L. (2010) · Immunology · doi:10.1111/j.1365-2567.2009.03240.x · Cited by 894
Self-citationHueber, W., Patel, D. D., Dryja, T., Wright, A. M., Koroleva, I., Bruin, G., Antoni, C., Draelos, Z., Gold, M. H., the Psoriasis Study Group, et al. (2010) · Science Translational Medicine · doi:10.1126/scitranslmed.3001107 · Cited by 860
IL-17 Signaling: The Yin and the Yang
Amatya, N., Garg, A. V., & Gaffen, S. L. (2017) · Trends in Immunology · doi:10.1016/j.it.2017.01.006 · Cited by 785 · cited 8×
“Notably, many of these inhibitory pathways converge on NF-kB activation (3).”
BackgroundSelf-citationInterleukin 17 is a chief orchestrator of immunity
Veldhoen, M. (2017) · Nature Immunology · doi:10.1038/ni.3742 · Cited by 475 · cited 6×
“For example, ABIN-1 levels decreased after TLR and TNF-a stimulation of bone marrow–derived macrophages with approximately the same kinetics as we observed with IL-17 signaling (35).”
BackgroundInfluentialIL-17–Mediated Immunity to the Opportunistic Fungal Pathogen Candida albicans
Conti, H. R., & Gaffen, S. L. (2015) · The Journal of Immunology · doi:10.4049/jimmunol.1500909 · Cited by 301 · cited 2×
“IL-17 is required to clear extracellular pathogens, particularly fungi such asCandida albicans (1).”
BackgroundSelf-citation
Cited by
The IL-17 Family of Cytokines in Health and Disease
McGeachy, M. J., Cua, D. J., & Gaffen, S. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.03.021 · Cited by 1,443
“Conversely, IL-17-NF-κB signaling induces several negative feedback circuits that restrain NF-κB activation, including deubiquitinating enzymes or related factors, including A20 (TNFAIP3), Abin-1 (TNIP1) and USP25 (Cruz et al., 2017; Garg et al., 2013; Zhong et al., 2012) (Figure 4).”
BackgroundSelf-citationCornel, A. M., Mimpen, I. L., & Nierkens, S. (2020) · Cancers · doi:10.3390/cancers12071760 · Cited by 464
“Similar to N4BP1, TNIP1 inhibits NFkB by impairing NEMO-mediated translocation of IKK to the receptor site.”
BackgroundInfluentialInterleukin-17A: The Key Cytokine in Neurodegenerative Diseases
Chen, J., Liu, X., & Zhong, Y. (2020) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2020.566922 · Cited by 164
“However, IL-17- NFκB signaling induces several negative feedback circuits to restrain the activation of NF-κB, such as deubiquitination (Garg et al., 2013; Cruz et al., 2017).”
TNIP1 in Autoimmune Diseases: Regulation of Toll-like Receptor Signaling
Shamilov, R., & Aneskievich, B. J. (2018) · Journal of Immunology Research · doi:10.1155/2018/3491269 · Cited by 79
“Interestingly, cultured cells experimentally exposed to IL-17a showed increased rates of TNIP1 protein degradation [113].”
BackgroundSelf-citationTh17 Cells in Helicobacter pylori Infection: a Dichotomy of Help and Harm
Dixon, B. R. E. A., Hossain, R., Patel, R. V., & Algood, H. M. S. (2019) · Infection and Immunity · doi:10.1128/iai.00363-19 · Cited by 58
“Moreover, they also reported that the A20-binding inhibitor of NF- B activation 1 (ABIN-1) negatively regulates the IL-17-induced production of Il6, Lcn2, and a few other NF- B-dependent genes in fibroblasts and stromal cells (97).”
Background
Metadata
- Authors
- Cruz, J. A., Childs, E. E., Amatya, N., Garg, A. V., Beyaert, R., Kane, L. P., Aneskievich, B. J., Ma, A., & Gaffen, S. L.
- Affiliations
- University of Pittsburgh (US)
- Ghent University (BE)
- Department of Immunology, University of Pittsburgh School of Medicine , Pittsburgh, PA 15261
- University of Connecticut (US)
- University of California, San Francisco (US)
- Corresponding author
- Amatya, Nilesh
- ORCID
- Venue
- ImmunoHorizons
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-09-01
- Volume
- 1
- Issue
- 7
- Pages
- 133-141
- ISSN
- 2573-7732 (ISSN-L)
- PMC
- PMC6370333
- OpenAlex
- W2751489398
- Cited by
- 29
- References
- 44
- Citations by year
- 2026: 3 · 2025: 4 · 2024: 6 · 2023: 1 · 2022: 2 · 2021: 2 · 2020: 7 · 2019: 2 · 2018: 2
- FWCI
- 1.01
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- ImmunoHorizons (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Ghent University Academic Bibliography (Ghent University) (submittedVersion, cc-by)
- Funders
- National Institutes of Health
- National Institute of Allergy and Infectious Diseases (R01AI103022, R01AI107825)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (R01AR048660)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Immunology and Microbiology › Immunology › Psoriasis: Treatment and Pathogenesis
- Life Sciences › Immunology and Microbiology › Immunology › Cytokine Signaling Pathways and Interactions
- Keywords
- IL-17 signaling, NF-κB activation, protein degradation, proteasome, A20, TNIP1, negative feedback regulation, fibroblasts, psoriasis, autoimmune disease susceptibility, inflammatory gene expression
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: IL-17 Signaling Triggers Degradation of the Constitutive NF-κB Inhibitor ABIN-1. https://app.cochat.ai/papers/10.4049/immunohorizons.1700035
- The paper
- Cruz, J. A., Childs, E. E., Amatya, N., Garg, A. V., Beyaert, R., Kane, L. P., Aneskievich, B. J., Ma, A., & Gaffen, S. L. (2017). IL-17 Signaling Triggers Degradation of the Constitutive NF-κB Inhibitor ABIN-1. ImmunoHorizons. https://doi.org/10.4049/immunohorizons.1700035
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.